VALIDATE Annual Meeting 2023 - Posters
Along with keynote talks, research presentations by VALIDATE-funded projects, and time for networking, we aim to hold a Poster Session at the Annual Meeting, so that more VALIDATE members can publicise their research.
You can find a full list of presenters, and their titles and abstracts, below:
Quaid-i-Azam University, Islamabad, Pakistan
Ecological Niche Modeling and clinico-epidemiological distribution of cutaneous leishmaniasis among inhabitants of Khyber Pakhtunkhwa, Pakistan (abstract)
University of Rajshahi, Bangladesh
Immune modulation of autophagy represents a promising strategy for host-directed therapy against mycobacteria (abstract)
Institute of Experimental Medicine (IMEX), CONICET-National Academy of Medicine, Argentina
Rewiring of Macrophage Metabolism By Lipid Mediators Derived From Omega-3 Fatty Acids: Its Impact on The Control Of Mycobacterium Tuberculosis Infection (abstract)
Global Institute for Interdisciplinary Studies, Nepal
Nepal: An urgent need to generate evidence through global collaboration (abstract)
National Institute of Agricultural Technology (INTA), Argentina
Comparative transcriptomic profiles of bovine differentiated macrophages and autologous lymphocytes co-cultures infected with two M. bovis isolates of opposite virulence phenotypes reveals a differential upregulation of type I IFN pathway genes (abstract)
University of Nevada, Reno School of Medicine, USA
Development of Scalable Processes to Facilitate GMP‐Compliant Production of a Melioidosis Subunit Vaccine Candidate (abstract)
University of Nevada, Reno School of Medicine, USA
Optimization of Serological Assays for the Analysis of Antigen-Specific Antibody Responses in Melioidosis Patients (abstract)
University of Otago, New Zealand
Investigating the evasion of BCG-mediated trained innate immune responses by Beijing-Mtb (abstract)
Manipal Academy of Higher Education, India
Genomic and biochemical characterization of ‘novel’ Burkholderia pseudomallei clinical isolates from Melioidosis and Neuromelioidosis patients from Southern India and their virulome and phylogenomic profiling (abstract)
Stellenbosch University, South Africa
Biomimetic nanoparticle-based host-directed therapy for the eradication of Mycobacterium tuberculosis (abstract)
Institut Pasteur de Tunis, Tunisia
Activation of the Host FOXO3 during BCG vaccination confers higher protection against Mycobacterium tuberculosis (abstract)
University of Delhi South Campus, India
Adjuvants for vaccine: receptor ligand based molecular interaction to discover adjuvants for human toll like receptors (abstract)
University of Oxford, UK
Developing a Controlled Human Infection Model with Intradermal or Aerosol BCG as a Surrogate for M. tb Infection (abstract)
ICMR - National Institute for Research in Tuberculosis, India
Impact Of Recent Covid-19 Infection on Neutrophil Extracellular Traps Formed During Tuberculosis (abstract)
Haramaya University, Ethiopia
Prevalence, Risk Factors and Public Health Importance of Bovine Tuberculosis in Eastern Ethiopia (abstract)
University of Reading, UK
The ESX-1 secretion-associated protein EspA may mediate liquid-liquid phase separation (abstract)
Banaras Hindu University India, India
Distinct CD4 + T Cells Immunological Signature in Patients with Post Kala-Azar Dermal Leishmaniasis (abstract)
Ms Millicent Naa Koshie Lamptey
Kumasi Center for Collaborative Research in Tropical Medicine, Ghana
Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patients (abstract)
University of Birmingham, UK
Integration of comprehensive tuberculosis clinical data, functional ex vivo mycobacterial growth inhibition assays and mass cytometry data to understand the reciprocal impact of M.tb and Covid-1 (abstract)
Bayero University, Nigeria
An Assessment Of Percentage and Absolute Cd4 Lymphocytes Levels and Factors Influencing Their Levels in Tuberculosis Patients Receiving Treatment n Barau Dikko Teaching Hospital, Kaduna, Nigeria (abstract)
Stellenbosch University, South Africa
Ferrocenyl-sulfonamide Derivatives as Anti-mycobacterial Agents (abstract)
Karolinska Institute, Sweden
Network-based analysis reveals a plasma protein signature associated with active Tuberculosis (abstract)
Professor Tufária Nazimo Ibrahimo Mussá
Faculty of Medicine, Eduardo Mondlane University, Mozambique
Diabetes Mellitus and cytokine profile in new Tuberculosis subjects with or without HIV in Maputo-south Mozambique (abstract)
Medical Research Council The Gambia at London School of Hygiene and Tropical Medicine, The Gambia
Analysis of the impact of monocytes differentiation on Mycobacterium tuberculosis complex infection (abstract)
MRC/UVRI and LSHTM Uganda Research Unit, Uganda
Effect of Intensive Treatment For Schistosomiasis, and of The Rural-Urban Environment, on Vaccine-Specific Immune Responses in Ugandan Adolescents (abstract)
MRC Unit the Gambia, Gambia
The role of macrophage differentiation on Mycobacterium tuberculosis complex lineages response to Tyrosine kinase inhibitors. (abstract)
UK Health Security Agency, UK
Characterisation of the infant immune system and the influence and immunogenicity of BCG vaccination in infant and adult rhesus macaques (abstract)
University of the Punjab, Pakistan
Balance between Protection and Pathogenic Response to Aerosol Challenge with Mycobacterium tuberculosis (Mtb) in Mice Vaccinated with TriFu64, a Fusion Consisting of Three Mtb Antigens (abstract)
Central University of Rajasthan, India
Mycobacterium tuberculosis Protein Tyrosine Phosphatase B as Vaccine Candidate against Tuberculosis (abstract)
MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda
A randomised clinical trial investigating the effect of BCG revaccination on the response to unrelated vaccines in Ugandan adolescents (abstract)
